Phase 2 study for people with Prostate Cancer

Recruiting Phase 2

Sources: ClinicalTrials.gov Checked: 13 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 2
Sponsor Genentech, Inc.
Registry number NCT07567846
Started 29 April 2026 Today 16 October 2026 Estimated completion 30 November 2027

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
St Vincent's Hospital Sydney Darlinghurst NSW Recruiting
Austin Hospital Heidelberg VIC Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 13 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Male participants only
Healthy volunteers Not accepted
Enrolment target 260

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* Eastern Cooperative Oncology Group (ECOG) Performance Status of \<=1

* Life expectancy is \>= 3 months

* Histologically or cytologically confirmed prostate adenocarcinoma

* Disease progression during or following the direct prior line of therapy

* Ongoing androgen deprivation therapy (ADT) with gonadotropin-releasing hormone (GnRH) agonist or antagonist, or have had bilateral orchiectomy

* Metastatic disease

* Adequate end organ function

Exclusion Criteria:

* Treatment with any approved systemic anti-cancer therapy within 14 days or 5 drug elimination half-lives

* Structurally unstable bone lesions suggest an impending fracture

* Untreated central nervous system (CNS) metastases or leptomeningeal disease

* Uncontrolled pain

* History of malignancy within 5 years

* Infection requiring systemic IV antibiotics within 14 days or oral antibiotics within 7 days prior to screening, or any evidence of current infection

* Any medical condition or abnormal clinical laboratory finding that, in the investigator's judgment, would preclude the individual's safe participation in and completion of the study or could affect the interpretation of the results

Dates on the record

Started 29 April 2026
Estimated completion 30 November 2027
Registry last updated 6 October 2026
Checked by Voxsanity 13 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 6 October 2026.
  • This page last checked by Voxsanity: 13 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.